## Gene Summary
GSTM3, short for Glutathione S-transferase Mu 3, is a crucial enzyme in the GST family that plays a significant role in the detoxification of the body by conjugating reduced glutathione to a wide variety of exogenous and endogenous compounds. This gene is part of the glutathione S-transferase mu family, a group known for their ability to catalyze the conjugation of glutathione to lipid-soluble toxins, aiding in their solubilization and excretion. GSTM3 is abundantly expressed in tissues like the liver and colon, where active detoxification processes occur.

## Gene Drugs, Diseases, Phenotypes, and Pathways
The GSTM3 gene is implicated in various cellular processes including drug metabolism and detoxification, responses to oxidative stress, and apoptosis. Polymorphisms in this gene have been studied in the context of susceptibility to cancers - notably lung, bladder, and breast cancers - due to its role in detoxifying potential carcinogens. Additionally, GSTM3 is also connected to pathways that deal with the metabolism and action of drugs and xenobiotics, thus playing a part in pharmacokinetics and pharmacodynamics.

## Pharmacogenetics
Pharmacogenetics studies concerning GSTM3 have illustrated its significant contributions to interindividual differences in the metabolism of and response to multiple drugs, though specific, widely acknowledged drug examples remain less documented compared to other genes in the GST family. However, the gene's involvement in detoxification and oxidative stress response pathways does suggest potential implications in drug response variability. Research continues into how GSTM3 polymorphisms might affect the efficacy and toxicity of drugs, particularly in chemotherapy and the treatment of chronic diseases where oxidative stress is a factor.